Catalyst Wire Dossier Catalyst Wire Dossier

VIS Opti-K System

· VIS, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VIS Opti-K System, covering 2024-09-05 to 2024-09-05. Get the full timeline:

Most recent: Clinical Trial Update: Phase III Presbyopia Correction Using the VIS Opti-K™ System [Phase 3]

See pricing